REVIEW article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1561702
This article is part of the Research TopicTraditional, Complementary and Integrative Medicine – Opportunities for Managing and Treating Neurodegenerative Diseases and Ischaemic StrokeView all 11 articles
INTEGRATIVE APPROACHES IN ALZHEIMER'S DISEASE: EVALUATING THE POTENTIAL OF TRADITIONAL, COMPLEMENTARY, AND INTEGRATIVE MEDICINE (TCIM)
Provisionally accepted- 1Dr. M.G.R. Educational and Research Institute, Chennai, Tamil Nadu, India
- 2Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
This review explores the potential of Traditional, Complementary, and Integrative Medicine (TCIM) as an adjunct to conventional therapies for Alzheimer's Disease (AD). Unlike pharmaceutical treatments that primarily offer symptomatic relief, TCIM encompasses holistic approaches that target multiple pathophysiological pathways involved in AD, including tau pathology, oxidative stress, mitochondrial dysfunction, and neuroinflammation. Herbal therapies such as Withania somnifera, Ginkgo biloba, and Curcuma longa have shown promising neuroprotective effects in preclinical and limited clinical studies. Mind-body practices like Kirtan Kriya meditation have also demonstrated stress-reduction benefits, addressing modifiable risk factors for AD. While current evidence highlights the potential of TCIM interventions to complement standard care, rigorous validation through high-quality randomized controlled trials remains essential. This review underscores the need for integrative, personalized approaches that synergize traditional and modern medical systems to enhance therapeutic outcomes in AD.
Keywords: Alzheimer's disease (AD), traditional medicine, Complementary and Integrative Medicine (TCIM), herbal therapies, Neuroinflammation, cognitive decline
Received: 16 Jan 2025; Accepted: 04 Jun 2025.
Copyright: © 2025 R, T, Begum, T, V, N and Singh S. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Rukaiah Fatma Begum, Institute of Pharmaceutical Research, GLA University, Mathura, 281406, Uttar Pradesh, India
Ankul Singh S, Dr. M.G.R. Educational and Research Institute, Chennai, 600 017, Tamil Nadu, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.